Table 1.
Model | Dose | Mechanism | Key findings | Ref. |
---|---|---|---|---|
Hypercholesterolemic subjects | Naringin, 400mg/capsule/day | Decreased plasma total cholesterol (TC), LDL, and Apo B; increased erythrocyte SOD and CAT activity | Lowering blood lipid, antioxidant | [183] |
Patients with moderate hypercholesterolemia | Naringin, 500mg/capsule/day |
TC and LDL cholesterol (LDL-C) concentrations are not reduced | Naringin does not lower blood lipids in patients with moderately high cholesterol | [184] |
Adult patients with dyslipidemia | Naringin. 450 mg/day |
TC, LDL, and TG decreased; lipocalin increased slightly | Reducing weight in patients with dyslipidemia | [102] |
Prediabetes patients | Citrus Flavonoid Supplement (4 % Naringin). 200, 400, or 800 mg/day for 12 weeks |
Decreased fasting glucose, HOMA-IR, HbA1c, glucagon, C-peptide, hsCRP, IL-6, and TNF-α; increased GLP-1, lipocalin in the blood. | Anti-inflammatory, anti-hyperglycemic and antioxidant | [185] |
Patients with T2DM and mixed hyperlipidemia | 650 mg of the BPF powder (BPF, main ingredient naringin) | LDL particles (LDL-P), TC, LDL-C, TG, blood glucose reduction | Lowering of blood glucose and blood lipids, complementary treatment of cardiometabolic disorders | [186,187] |
T2DM | Mediterranean Diet (naringenin, naringin) | Decreased IL-6, oxidative stress marker 8-hydroxy-2′-deoxyguanosine (8-OHdG) | Reducing Inflammation in T2DM | [188] |
Participants with abdominal obesity/dyslipidemia | 1240 mg/day total polyphenols (naringin, naringenin) | Increases fatty acid oxidation in the liver, reduces inflammation by inhibiting nuclear factor κ-light chain enhancers in activated B cells, increases lipocalin | Blood pressure lowering, diet program to treat NAFLD. | [189] |
older adults experiencing subjective cognitive decline (SCD) | 400 mg Citrus Peel Extract (naringenin 3 mg) | IL-10, IL1-Ra, soluble TNF receptor I, soluble TNF receptor II increased; CXCL8/IL-8, IL-1β, IL-6, IL-17, TNF-α, IP10, MIP-1α, CCL2/MCP-1, CCL5/RANTES, IL-18, NO, thiobarbituric acid reactive substances, SOD decreased | Improves immediate memory, visuospatial/structural, language, attention, and delayed memory; reduces oxidative stress and neuronal damage and anti-inflammatory effects | [190] |
Healthy volunteers | Felodipine with 250 mL grapefruit juice | Significantly inhibited CYP3A4 activity | Peak concentrations were higher, but half-life was unchanged. Grapefruit juice significantly increased the bioavailability of felodipine | [[191], [192], [193]] |
Healthy volunteers | aliskiren with 300 mL grapefruit juice | Naringin inhibits human intestinal organic anion transporting polypeptide (OATP) 1A2 | Reducing exposure to aliskiren | [194] |
Healthy volunteers | Fexofenadine with 300 ml grapefruit juice | Naringin inhibits the OATP1A2 part of the intestine | Reduces the bioavailability of oral fexofenadine | [195] |
Healthy volunteers | talinolol and 1050 mg of naringin | The high dose may inhibit the efflux transporter protein P-glycoprotein (P-gp), counteracting uptake inhibition. | Short-term high-dose supplementation with naringin does not affect the pharmacokinetics of talinolol. | [196] |
Healthy volunteers | Nisoldipine coated tablets with 250 ml water, 250 ml grapefruit juice | Increasing the maximum concentration of nisoldipine and decreasing the time to reach the maximum concentration | [197] |